Obesity and demographic ageing are two global megatrends that overlap in a particularly unfavorable way in the cardiovascular system. Both factors independently increase the risk of cardiovascular disease, but also interact at common biological levels: from cellular senescence and mitochondrial dysfunction to structural cardiac and vascular remodeling. The state-of-the-art review by Ruperez et al. in the European Heart Journal sheds light on how obesity accelerates biological cardiovascular ageing, which mechanistic intersections can be found and which metabolic therapy strategies – from calorie restriction to GLP-1 receptor agonists and SGLT2 inhibitors – can modulate these processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Exercise for type 1 diabetes
Cyclists and runners with an increased risk of hypoglycemia
- Ozanimod for relapsing-remitting multiple sclerosis
Signs of improved tolerability with prolonged treatment
- When basal cell carcinomas prove difficult to treat
Reaching the goal with innovative therapy strategies
- Irritable Bowel Syndrome
IBS or endometriosis?
- Type 2 diabetes: sarcopenia and frailty
How can the breakdown of skeletal muscles be stopped?
- Cholangiocarcinoma
Modern molecular diagnostics and targeted therapy options
- Treatment resistant depression
Esketamine nasal spray as monotherapy? New for treatment-resistant depression
- Analysis of SNVCS data from the period 2005-2022